Eligibility and Preventive Potential for New Evidence-Based Cardiovascular Drugs in Secondary Prevention

Martin Bødtker Mortensen, Michael Joseph Blaha, Børge Grønne Nordestgaard

Research output: Contribution to journalReview articlepeer-review

Fingerprint Dive into the research topics of 'Eligibility and Preventive Potential for New Evidence-Based Cardiovascular Drugs in Secondary Prevention'. Together they form a unique fingerprint.

Medicine & Life Sciences